SEC Form 4 · accession 0001140361-18-027713
Emergent BioSolutions Inc. · EBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel Abdun-Nabi
Officer — Chief Executive Officer · Director
Period of report
Jun 5, 2018
Accepted (ET)
Jun 7, 2018 · 5:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 5, 2018 | S | 15,785 | $52.1137 | D | 197,343 | D | |
| Common StockF2 | holding | — | — | — | 1,936 | I | By Son |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.83 to $52.66. inclusive.
- F2The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
Remarks
Exhibit List: EXHIBIT 24.1 Power of Attorney